Donald Bergstrom
Technik-/Wissenschafts-/F&E-Leiter bei RELAY THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
André Choulika | M | 59 |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | 25 Jahre |
Alexis Borisy | M | 52 | 9 Jahre | |
David Sourdive | M | 57 | 25 Jahre | |
Mark Murcko | M | 64 | 9 Jahre | |
Imogen Pryce | M | - | 4 Jahre | |
Anna Protopapas | F | 59 | 9 Jahre | |
Sanjiv Patel | M | 50 | 7 Jahre | |
Stephan Reynier | M | 55 | 13 Jahre | |
Mark Frattini | M | 58 | 4 Jahre | |
Sekar Kathiresan | M | 52 | 2 Jahre | |
Rainer Boehm | M | 63 | 7 Jahre | |
Marie-Bleuenn Terrier | F | 42 | 16 Jahre | |
Willard Dere | M | 70 | 6 Jahre | |
Brian Adams | M | 50 | 6 Jahre | |
Kristen Hege | M | 60 | 8 Jahre | |
Lawrence Alleva | M | 74 | 7 Jahre | |
Douglas Ingram | M | 61 | 5 Jahre | |
Peter Rahmer | M | - | 4 Jahre | |
Pierre Bastid | M | 69 | 13 Jahre | |
Andrew Hack | M | 50 | 7 Jahre | |
Laurent Arthaud | M | 61 | 13 Jahre | |
Laura Shawver | M | 66 | 7 Jahre | |
Jami Rubin | F | 60 | 5 Jahre | |
Axel-Sven Malkomes | M | 57 | 2 Jahre | |
Linda Hill | M | 67 | 6 Jahre | |
Philippe Duchateau | M | 61 | 23 Jahre | |
Patrick Riley | M | - | 3 Jahre | |
Pascalyne Wilson | M | - | - | |
Dmitri Bobilev | M | - | 2 Jahre | |
Jean-Pierre Garnier | M | 75 | 4 Jahre | |
Jeanne Gray | F | - | - | |
Arthur Stril | M | 35 | 6 Jahre | |
Thomas Catinazzo | M | 47 | 6 Jahre | |
Kyung Nam-Wortman | F | 54 | 4 Jahre | |
Steve Doares | M | - | 4 Jahre | |
Ben Wolf | M | - | 5 Jahre | |
Dan Budwick | M | - | - | |
Christopher Leamon | M | 57 | 3 Jahre | |
Eric S. Hoffman | M | 54 | 3 Jahre | |
Cécile Chartier | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
John Valliant | M | 54 | 10 Jahre | |
Philina Lee | M | 47 | 3 Jahre | |
Pablo Cagnoni | M | 60 | 5 Jahre | |
Lynn Wick | F | - | 4 Jahre | |
Andy Porter | M | - | 4 Jahre | |
Herve Hoppenot | M | 64 | 6 Jahre | |
Gregory Irace | M | 65 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 Jahre |
Steven Kafka | M | 54 | 1 Jahre | |
Dipchand Nishar | M | 54 | 2 Jahre | |
Christoph S. Lengauer | M | 59 | - | |
Steven Gannon | M | 62 | 4 Jahre | |
Annick Schwebig | M | 73 | 12 Jahre | |
Johan Rutger Christenson | M | 65 | 6 Jahre | |
Elaine Jones | M | 69 | 3 Jahre | |
Chau Khuong | M | 48 | 4 Jahre | |
Heather Elizabeth Preston | M | 58 | 4 Jahre | |
Barbara Duncan | F | 59 | 4 Jahre | |
Andrew Franklin | M | 58 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 2 Jahre |
Michael J. Kaufman | M | 66 | 5 Jahre | |
Andrew Michael James Prosser | M | - |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | - |
Teresa Bitetti | F | - | 1 Jahre | |
Rosina B. Dixon | M | 81 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 5 Jahre |
David Spellman | M | 48 | 1 Jahre | |
Bing Wang | M | 47 | 2 Jahre | |
Carrie Brownstein | M | 54 | 2 Jahre | |
Susan Moran | M | 54 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
Margaret Gandolfo | F | - | - | |
Isabelle Dussault | M | - | 1 Jahre | |
Mohit Rawat | M | - | 3 Jahre | |
John Crowley | M | 51 | 5 Jahre | |
Markus Warmuth | M | 53 | 1 Jahre | |
David Meek | M | 59 | 1 Jahre | |
Jean-Pierre Lehner | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | - |
Richard A. Moscicki | M | 72 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 2 Jahre |
Sandy Smith | M | 77 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 15 Jahre |
Alain Munoz | M | 75 | - | |
Pankaj Bhargava | M | 54 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 3 Jahre |
James J. O'Leary | M | 60 | 2 Jahre | |
David Noskowitz | M | - | 2 Jahre | |
Nigel Brooksby | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | - |
Stefan Schwabe | M | 72 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 Jahre |
Donna M. Jarlenski | F | - | 6 Jahre | |
Deborah Palestrant | M | - | 1 Jahre | |
Christer Odqvist | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 9 Jahre |
Debasish Francois Roychowdhury | M | 63 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 Jahre |
Jeremy Bender | M | 52 | 1 Jahre | |
David Malek | M | 47 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 5 Jahre |
Jaideep Dudani | M | - | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 43 | 48,86% |
Frankreich | 22 | 25,00% |
Kanada | 19 | 21,59% |
Vereinigtes Königreich | 5 | 5,68% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Donald Bergstrom
- Persönliches Netzwerk